0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Children Long-Acting Growth Hormone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-1Y13734
Home | Market Reports | Health| Pharmacy
Global Children Long Acting Growth Hormone Market Research Report 2023
BUY CHAPTERS

Children Long-Acting Growth Hormone - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-1Y13734
Report
October 2024
Pages:120
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Children Long-Acting Growth Hormone - Market Size

The global market for Children Long-Acting Growth Hormone was estimated to be worth US$ 8792 million in 2023 and is forecast to a readjusted size of US$ 13440 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030

Children Long-Acting Growth Hormone - Market

Children Long-Acting Growth Hormone - Market

According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Children Long-Acting Growth Hormone, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Children Long-Acting Growth Hormone by region & country, by Type, and by Application.
The Children Long-Acting Growth Hormone market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Children Long-Acting Growth Hormone.
Market Segmentation

Scope of Children Long-Acting Growth Hormone - Market Report

Report Metric Details
Report Name Children Long-Acting Growth Hormone - Market
Forecasted market size in 2030 US$ 13440 million
CAGR 6.3%
Forecasted years 2024 - 2030
Segment by Type:
  • Powder
  • Solvent
Segment by Application
  • Growth Hormone Deficiency (GHD)
  • Turner Syndrome
  • Chronic Renal Insufficiency
  • Prader Willi Syndrome
  • Small for Gestational Age(SGA)
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Children Long-Acting Growth Hormone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Children Long-Acting Growth Hormone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Children Long-Acting Growth Hormone in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Children Long-Acting Growth Hormone - Market size in 2030?

Ans: The Children Long-Acting Growth Hormone - Market size in 2030 will be US$ 13440 million.

What is the Children Long-Acting Growth Hormone - Market share by region?

Ans: According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million.

Who are the main players in the Children Long-Acting Growth Hormone - Market report?

Ans: The main players in the Children Long-Acting Growth Hormone - Market are Pfizer, Novo Nordisk, Eli Lilly, Merck Serono, F. Hoffmann-La Roche, Ferring Pharmaceuticals, Ipsen, LG Life Sciences, Sandoz International, Anhui Anke Biotechnology

What are the Application segmentation covered in the Children Long-Acting Growth Hormone - Market report?

Ans: The Applications covered in the Children Long-Acting Growth Hormone - Market report are Growth Hormone Deficiency (GHD), Turner Syndrome, Chronic Renal Insufficiency, Prader Willi Syndrome, Small for Gestational Age(SGA), Others

What are the Type segmentation covered in the Children Long-Acting Growth Hormone - Market report?

Ans: The Types covered in the Children Long-Acting Growth Hormone - Market report are Powder, Solvent

1 Market Overview
1.1 Children Long-Acting Growth Hormone Product Introduction
1.2 Global Children Long-Acting Growth Hormone Market Size Forecast
1.2.1 Global Children Long-Acting Growth Hormone Sales Value (2019-2030)
1.2.2 Global Children Long-Acting Growth Hormone Sales Volume (2019-2030)
1.2.3 Global Children Long-Acting Growth Hormone Sales Price (2019-2030)
1.3 Children Long-Acting Growth Hormone Market Trends & Drivers
1.3.1 Children Long-Acting Growth Hormone Industry Trends
1.3.2 Children Long-Acting Growth Hormone Market Drivers & Opportunity
1.3.3 Children Long-Acting Growth Hormone Market Challenges
1.3.4 Children Long-Acting Growth Hormone Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Children Long-Acting Growth Hormone Players Revenue Ranking (2023)
2.2 Global Children Long-Acting Growth Hormone Revenue by Company (2019-2024)
2.3 Global Children Long-Acting Growth Hormone Players Sales Volume Ranking (2023)
2.4 Global Children Long-Acting Growth Hormone Sales Volume by Company Players (2019-2024)
2.5 Global Children Long-Acting Growth Hormone Average Price by Company (2019-2024)
2.6 Key Manufacturers Children Long-Acting Growth Hormone Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Children Long-Acting Growth Hormone Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Children Long-Acting Growth Hormone
2.9 Children Long-Acting Growth Hormone Market Competitive Analysis
2.9.1 Children Long-Acting Growth Hormone Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Children Long-Acting Growth Hormone Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Long-Acting Growth Hormone as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Powder
3.1.2 Solvent
3.2 Global Children Long-Acting Growth Hormone Sales Value by Type
3.2.1 Global Children Long-Acting Growth Hormone Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Children Long-Acting Growth Hormone Sales Value, by Type (2019-2030)
3.2.3 Global Children Long-Acting Growth Hormone Sales Value, by Type (%) (2019-2030)
3.3 Global Children Long-Acting Growth Hormone Sales Volume by Type
3.3.1 Global Children Long-Acting Growth Hormone Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Children Long-Acting Growth Hormone Sales Volume, by Type (2019-2030)
3.3.3 Global Children Long-Acting Growth Hormone Sales Volume, by Type (%) (2019-2030)
3.4 Global Children Long-Acting Growth Hormone Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Growth Hormone Deficiency (GHD)
4.1.2 Turner Syndrome
4.1.3 Chronic Renal Insufficiency
4.1.4 Prader Willi Syndrome
4.1.5 Small for Gestational Age(SGA)
4.1.6 Others
4.2 Global Children Long-Acting Growth Hormone Sales Value by Application
4.2.1 Global Children Long-Acting Growth Hormone Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Children Long-Acting Growth Hormone Sales Value, by Application (2019-2030)
4.2.3 Global Children Long-Acting Growth Hormone Sales Value, by Application (%) (2019-2030)
4.3 Global Children Long-Acting Growth Hormone Sales Volume by Application
4.3.1 Global Children Long-Acting Growth Hormone Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Children Long-Acting Growth Hormone Sales Volume, by Application (2019-2030)
4.3.3 Global Children Long-Acting Growth Hormone Sales Volume, by Application (%) (2019-2030)
4.4 Global Children Long-Acting Growth Hormone Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Children Long-Acting Growth Hormone Sales Value by Region
5.1.1 Global Children Long-Acting Growth Hormone Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Children Long-Acting Growth Hormone Sales Value by Region (2019-2024)
5.1.3 Global Children Long-Acting Growth Hormone Sales Value by Region (2025-2030)
5.1.4 Global Children Long-Acting Growth Hormone Sales Value by Region (%), (2019-2030)
5.2 Global Children Long-Acting Growth Hormone Sales Volume by Region
5.2.1 Global Children Long-Acting Growth Hormone Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Children Long-Acting Growth Hormone Sales Volume by Region (2019-2024)
5.2.3 Global Children Long-Acting Growth Hormone Sales Volume by Region (2025-2030)
5.2.4 Global Children Long-Acting Growth Hormone Sales Volume by Region (%), (2019-2030)
5.3 Global Children Long-Acting Growth Hormone Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Children Long-Acting Growth Hormone Sales Value, 2019-2030
5.4.2 North America Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Children Long-Acting Growth Hormone Sales Value, 2019-2030
5.5.2 Europe Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Children Long-Acting Growth Hormone Sales Value, 2019-2030
5.6.2 Asia Pacific Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Children Long-Acting Growth Hormone Sales Value, 2019-2030
5.7.2 South America Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Children Long-Acting Growth Hormone Sales Value, 2019-2030
5.8.2 Middle East & Africa Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Children Long-Acting Growth Hormone Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Children Long-Acting Growth Hormone Sales Value
6.2.1 Key Countries/Regions Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.2.2 Key Countries/Regions Children Long-Acting Growth Hormone Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.3.2 United States Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.4.2 Europe Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.5.2 China Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.5.3 China Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.6.2 Japan Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.7.2 South Korea Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.8.2 Southeast Asia Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Children Long-Acting Growth Hormone Sales Value, 2019-2030
6.9.2 India Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
6.9.3 India Children Long-Acting Growth Hormone Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Children Long-Acting Growth Hormone Product Offerings
7.1.5 Pfizer Recent Development
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Information
7.2.2 Novo Nordisk Introduction and Business Overview
7.2.3 Novo Nordisk Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novo Nordisk Children Long-Acting Growth Hormone Product Offerings
7.2.5 Novo Nordisk Recent Development
7.3 Eli Lilly
7.3.1 Eli Lilly Company Information
7.3.2 Eli Lilly Introduction and Business Overview
7.3.3 Eli Lilly Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eli Lilly Children Long-Acting Growth Hormone Product Offerings
7.3.5 Eli Lilly Recent Development
7.4 Merck Serono
7.4.1 Merck Serono Company Information
7.4.2 Merck Serono Introduction and Business Overview
7.4.3 Merck Serono Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Merck Serono Children Long-Acting Growth Hormone Product Offerings
7.4.5 Merck Serono Recent Development
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Information
7.5.2 F. Hoffmann-La Roche Introduction and Business Overview
7.5.3 F. Hoffmann-La Roche Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.5.4 F. Hoffmann-La Roche Children Long-Acting Growth Hormone Product Offerings
7.5.5 F. Hoffmann-La Roche Recent Development
7.6 Ferring Pharmaceuticals
7.6.1 Ferring Pharmaceuticals Company Information
7.6.2 Ferring Pharmaceuticals Introduction and Business Overview
7.6.3 Ferring Pharmaceuticals Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ferring Pharmaceuticals Children Long-Acting Growth Hormone Product Offerings
7.6.5 Ferring Pharmaceuticals Recent Development
7.7 Ipsen
7.7.1 Ipsen Company Information
7.7.2 Ipsen Introduction and Business Overview
7.7.3 Ipsen Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ipsen Children Long-Acting Growth Hormone Product Offerings
7.7.5 Ipsen Recent Development
7.8 LG Life Sciences
7.8.1 LG Life Sciences Company Information
7.8.2 LG Life Sciences Introduction and Business Overview
7.8.3 LG Life Sciences Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.8.4 LG Life Sciences Children Long-Acting Growth Hormone Product Offerings
7.8.5 LG Life Sciences Recent Development
7.9 Sandoz International
7.9.1 Sandoz International Company Information
7.9.2 Sandoz International Introduction and Business Overview
7.9.3 Sandoz International Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Sandoz International Children Long-Acting Growth Hormone Product Offerings
7.9.5 Sandoz International Recent Development
7.10 Anhui Anke Biotechnology
7.10.1 Anhui Anke Biotechnology Company Information
7.10.2 Anhui Anke Biotechnology Introduction and Business Overview
7.10.3 Anhui Anke Biotechnology Children Long-Acting Growth Hormone Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Anhui Anke Biotechnology Children Long-Acting Growth Hormone Product Offerings
7.10.5 Anhui Anke Biotechnology Recent Development
8 Industry Chain Analysis
8.1 Children Long-Acting Growth Hormone Industrial Chain
8.2 Children Long-Acting Growth Hormone Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Children Long-Acting Growth Hormone Sales Model
8.5.2 Sales Channel
8.5.3 Children Long-Acting Growth Hormone Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Children Long-Acting Growth Hormone Market Trends
    Table 2. Children Long-Acting Growth Hormone Market Drivers & Opportunity
    Table 3. Children Long-Acting Growth Hormone Market Challenges
    Table 4. Children Long-Acting Growth Hormone Market Restraints
    Table 5. Global Children Long-Acting Growth Hormone Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Children Long-Acting Growth Hormone Revenue Market Share by Company (2019-2024)
    Table 7. Global Children Long-Acting Growth Hormone Sales Volume by Company (2019-2024) & (Tons)
    Table 8. Global Children Long-Acting Growth Hormone Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Children Long-Acting Growth Hormone Price by Company (2019-2024) & (US$/Ton)
    Table 10. Key Manufacturers Children Long-Acting Growth Hormone Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Children Long-Acting Growth Hormone Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Children Long-Acting Growth Hormone
    Table 13. Global Children Long-Acting Growth Hormone Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Children Long-Acting Growth Hormone as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Children Long-Acting Growth Hormone Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Children Long-Acting Growth Hormone Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Children Long-Acting Growth Hormone Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Children Long-Acting Growth Hormone Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Children Long-Acting Growth Hormone Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Children Long-Acting Growth Hormone Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
    Table 22. Global Children Long-Acting Growth Hormone Sales Volume by Type (2019-2024) & (Tons)
    Table 23. Global Children Long-Acting Growth Hormone Sales Volume by Type (2025-2030) & (Tons)
    Table 24. Global Children Long-Acting Growth Hormone Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Children Long-Acting Growth Hormone Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Children Long-Acting Growth Hormone Price by Type (2019-2024) & (US$/Ton)
    Table 27. Global Children Long-Acting Growth Hormone Price by Type (2025-2030) & (US$/Ton)
    Table 28. Global Children Long-Acting Growth Hormone Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Children Long-Acting Growth Hormone Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Children Long-Acting Growth Hormone Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Children Long-Acting Growth Hormone Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Children Long-Acting Growth Hormone Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Children Long-Acting Growth Hormone Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
    Table 34. Global Children Long-Acting Growth Hormone Sales Volume by Application (2019-2024) & (Tons)
    Table 35. Global Children Long-Acting Growth Hormone Sales Volume by Application (2025-2030) & (Tons)
    Table 36. Global Children Long-Acting Growth Hormone Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Children Long-Acting Growth Hormone Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Children Long-Acting Growth Hormone Price by Application (2019-2024) & (US$/Ton)
    Table 39. Global Children Long-Acting Growth Hormone Price by Application (2025-2030) & (US$/Ton)
    Table 40. Global Children Long-Acting Growth Hormone Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Children Long-Acting Growth Hormone Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Children Long-Acting Growth Hormone Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Children Long-Acting Growth Hormone Sales Value by Region (2019-2024) & (%)
    Table 44. Global Children Long-Acting Growth Hormone Sales Value by Region (2025-2030) & (%)
    Table 45. Global Children Long-Acting Growth Hormone Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
    Table 46. Global Children Long-Acting Growth Hormone Sales Volume by Region (2019-2024) & (Tons)
    Table 47. Global Children Long-Acting Growth Hormone Sales Volume by Region (2025-2030) & (Tons)
    Table 48. Global Children Long-Acting Growth Hormone Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Children Long-Acting Growth Hormone Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Children Long-Acting Growth Hormone Average Price by Region (2019-2024) & (US$/Ton)
    Table 51. Global Children Long-Acting Growth Hormone Average Price by Region (2025-2030) & (US$/Ton)
    Table 52. Key Countries/Regions Children Long-Acting Growth Hormone Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Children Long-Acting Growth Hormone Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Children Long-Acting Growth Hormone Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Children Long-Acting Growth Hormone Sales Volume, (2019-2024) & (Tons)
    Table 56. Key Countries/Regions Children Long-Acting Growth Hormone Sales Volume, (2025-2030) & (Tons)
    Table 57. Pfizer Company Information
    Table 58. Pfizer Introduction and Business Overview
    Table 59. Pfizer Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 60. Pfizer Children Long-Acting Growth Hormone Product Offerings
    Table 61. Pfizer Recent Development
    Table 62. Novo Nordisk Company Information
    Table 63. Novo Nordisk Introduction and Business Overview
    Table 64. Novo Nordisk Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 65. Novo Nordisk Children Long-Acting Growth Hormone Product Offerings
    Table 66. Novo Nordisk Recent Development
    Table 67. Eli Lilly Company Information
    Table 68. Eli Lilly Introduction and Business Overview
    Table 69. Eli Lilly Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 70. Eli Lilly Children Long-Acting Growth Hormone Product Offerings
    Table 71. Eli Lilly Recent Development
    Table 72. Merck Serono Company Information
    Table 73. Merck Serono Introduction and Business Overview
    Table 74. Merck Serono Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 75. Merck Serono Children Long-Acting Growth Hormone Product Offerings
    Table 76. Merck Serono Recent Development
    Table 77. F. Hoffmann-La Roche Company Information
    Table 78. F. Hoffmann-La Roche Introduction and Business Overview
    Table 79. F. Hoffmann-La Roche Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 80. F. Hoffmann-La Roche Children Long-Acting Growth Hormone Product Offerings
    Table 81. F. Hoffmann-La Roche Recent Development
    Table 82. Ferring Pharmaceuticals Company Information
    Table 83. Ferring Pharmaceuticals Introduction and Business Overview
    Table 84. Ferring Pharmaceuticals Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 85. Ferring Pharmaceuticals Children Long-Acting Growth Hormone Product Offerings
    Table 86. Ferring Pharmaceuticals Recent Development
    Table 87. Ipsen Company Information
    Table 88. Ipsen Introduction and Business Overview
    Table 89. Ipsen Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 90. Ipsen Children Long-Acting Growth Hormone Product Offerings
    Table 91. Ipsen Recent Development
    Table 92. LG Life Sciences Company Information
    Table 93. LG Life Sciences Introduction and Business Overview
    Table 94. LG Life Sciences Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 95. LG Life Sciences Children Long-Acting Growth Hormone Product Offerings
    Table 96. LG Life Sciences Recent Development
    Table 97. Sandoz International Company Information
    Table 98. Sandoz International Introduction and Business Overview
    Table 99. Sandoz International Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 100. Sandoz International Children Long-Acting Growth Hormone Product Offerings
    Table 101. Sandoz International Recent Development
    Table 102. Anhui Anke Biotechnology Company Information
    Table 103. Anhui Anke Biotechnology Introduction and Business Overview
    Table 104. Anhui Anke Biotechnology Children Long-Acting Growth Hormone Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 105. Anhui Anke Biotechnology Children Long-Acting Growth Hormone Product Offerings
    Table 106. Anhui Anke Biotechnology Recent Development
    Table 107. Key Raw Materials Lists
    Table 108. Raw Materials Key Suppliers Lists
    Table 109. Children Long-Acting Growth Hormone Downstream Customers
    Table 110. Children Long-Acting Growth Hormone Distributors List
    Table 111. Research Programs/Design for This Report
    Table 112. Key Data Information from Secondary Sources
    Table 113. Key Data Information from Primary Sources
List of Figures
    Figure 1. Children Long-Acting Growth Hormone Product Picture
    Figure 2. Global Children Long-Acting Growth Hormone Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Children Long-Acting Growth Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Children Long-Acting Growth Hormone Sales Volume (2019-2030) & (Tons)
    Figure 5. Global Children Long-Acting Growth Hormone Sales Price (2019-2030) & (US$/Ton)
    Figure 6. Children Long-Acting Growth Hormone Report Years Considered
    Figure 7. Global Children Long-Acting Growth Hormone Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Children Long-Acting Growth Hormone Players Sales Volume Ranking (2023) & (Tons)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Children Long-Acting Growth Hormone Revenue in 2023
    Figure 10. Children Long-Acting Growth Hormone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Powder Picture
    Figure 12. Solvent Picture
    Figure 13. Global Children Long-Acting Growth Hormone Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Children Long-Acting Growth Hormone Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Children Long-Acting Growth Hormone Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
    Figure 16. Global Children Long-Acting Growth Hormone Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Children Long-Acting Growth Hormone Price by Type (2019-2030) & (US$/Ton)
    Figure 18. Product Picture of Growth Hormone Deficiency (GHD)
    Figure 19. Product Picture of Turner Syndrome
    Figure 20. Product Picture of Chronic Renal Insufficiency
    Figure 21. Product Picture of Prader Willi Syndrome
    Figure 22. Product Picture of Small for Gestational Age(SGA)
    Figure 23. Product Picture of Others
    Figure 24. Global Children Long-Acting Growth Hormone Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 25. Global Children Long-Acting Growth Hormone Sales Value Market Share by Application, 2023 & 2030
    Figure 26. Global Children Long-Acting Growth Hormone Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
    Figure 27. Global Children Long-Acting Growth Hormone Sales Volume Market Share by Application, 2023 & 2030
    Figure 28. Global Children Long-Acting Growth Hormone Price by Application (2019-2030) & (US$/Ton)
    Figure 29. North America Children Long-Acting Growth Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 30. North America Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 31. Europe Children Long-Acting Growth Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 32. Europe Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 33. Asia Pacific Children Long-Acting Growth Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 34. Asia Pacific Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 35. South America Children Long-Acting Growth Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 36. South America Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 37. Middle East & Africa Children Long-Acting Growth Hormone Sales Value (2019-2030) & (US$ Million)
    Figure 38. Middle East & Africa Children Long-Acting Growth Hormone Sales Value by Country (%), 2023 VS 2030
    Figure 39. Key Countries/Regions Children Long-Acting Growth Hormone Sales Value (%), (2019-2030)
    Figure 40. Key Countries/Regions Children Long-Acting Growth Hormone Sales Volume (%), (2019-2030)
    Figure 41. United States Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 42. United States Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 43. United States Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 44. Europe Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Europe Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 46. Europe Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 47. China Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 48. China Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 49. China Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 50. Japan Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 51. Japan Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 52. Japan Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 53. South Korea Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 54. South Korea Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 55. South Korea Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 56. Southeast Asia Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 57. Southeast Asia Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 58. Southeast Asia Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 59. India Children Long-Acting Growth Hormone Sales Value, (2019-2030) & (US$ Million)
    Figure 60. India Children Long-Acting Growth Hormone Sales Value by Type (%), 2023 VS 2030
    Figure 61. India Children Long-Acting Growth Hormone Sales Value by Application (%), 2023 VS 2030
    Figure 62. Children Long-Acting Growth Hormone Industrial Chain
    Figure 63. Children Long-Acting Growth Hormone Manufacturing Cost Structure
    Figure 64. Channels of Distribution (Direct Sales, and Distribution)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global RANKL Inhibitors Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35Z18485
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Morphine Test Kit - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-28M18423
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Compound Antibacterial Agent for Animal - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-38V14855
Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Antipyretic Stickers Market Insights, Forecast to 2030

120 Pages
Type: Report
Code: QYRE-Auto-22E8302
Thu Dec 12 00:00:00 UTC 2024

Add to Cart